An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Revvity to Present at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Revvity, Inc. (NYSE: RVTY) will present at several investor conferences in February and March 2024, providing updates on the company's strategic priorities. Key executives like Max Krakowiak and Prahlad Singh will discuss the financial and operational aspects at these events.
Positive
None.
Negative
None.
WALTHAM, Mass.--(BUSINESS WIRE)--
Revvity, Inc. (NYSE: RVTY) today announced it will present at the following investor conferences in February and March 2024:
Attendees will receive an update on the Company and its strategic priorities.
Live audio webcasts will be available on the Events section of the Company’s website. Replays of the presentations will be posted on the Revvity Investor Relations website after the events and will be available for at least 30 days.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With 2023 revenue of more than $2.7 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.
When will Revvity, Inc. (RVTY) present at Citi's 2024 Unplugged MedTech and Life Sciences Access Day?
Revvity, Inc. (RVTY) will present at Citi's 2024 Unplugged MedTech and Life Sciences Access Day on Thursday, February 29, 2024, at 8:00 a.m. ET.
Who will be the senior vice president and chief financial officer presenting at Citi's 2024 Unplugged MedTech and Life Sciences Access Day for Revvity, Inc. (RVTY)?
Max Krakowiak, the senior vice president and chief financial officer, will present at Citi's 2024 Unplugged MedTech and Life Sciences Access Day for Revvity, Inc. (RVTY).
Which conference will Prahlad Singh, the president, and chief executive officer of Revvity, Inc. (RVTY) attend in March 2024?
Prahlad Singh, the president, and chief executive officer of Revvity, Inc. (RVTY) will attend the TD Cowen 44th Annual Health Care Conference in Boston, MA on Monday, March 4, 2024.
Where can attendees access live audio webcasts of the presentations by Revvity, Inc. (RVTY) executives?
Attendees can access live audio webcasts of the presentations by Revvity, Inc. (RVTY) executives on the Events section of the Company’s website.
For how long will replays of the presentations by Revvity, Inc. (RVTY) executives be available?
Replays of the presentations by Revvity, Inc. (RVTY) executives will be available on the Revvity Investor Relations website after the events and will be available for at least 30 days.
as a leader focused on improving human and environmental health, we are helping scientists, clinicians, and government agencies discover more effective diagnostics and therapies, and making sure that the food we eat and the air we breathe are safe from contaminants. environmental health overview at perkinelmer, we’re taking action to ensure the quality of our environment. the ability to rapidly detect known and unknown contaminants in our food, water and air, or to monitor their quality consistently, is an important part of maintaining a healthy environment. our systems and services help scientists understand all of these complexities and ensure compliance. from food safety to air & water quality, perkinelmer transforms information into results that improve our health and safety today and our world tomorrow. human health overview perkinelmer creates life science research and diagnostic instrumentation as well as informatics and diagnostic lab services—all to fight illness proacti
